TABLE 2.

Summary of ⁶⁸Ga-DOTATATE PET/CT Scans

Patient no.	Indication	GA	RT dose (mCi/MBq)	Concurrent anatomic imaging	Soft- tissue lesions	Bony lesions	Bone marrow involvement	Conclusion	Concordance
1	Restaging	Yes	2.16/80	MRI	Yes	No	No	Metastatic disease	Yes
2	Response	Yes	2/74	MRI	Yes	No	No	mIR	Yes
3	Staging	Yes	2.3/85.5	Radiography, ultrasound, MRI	Yes	Yes	Yes	Metastatic disease	Yes
4	Response	Yes	1.24/46	MRI	Yes	Yes	Yes	mIR	Yes
5	Response	Yes	1.2/44.6	MRI	Yes	Yes	Yes	mIR	Yes
6	Response	No	1.74/64.4	MRI	Yes	Yes	Yes	PD	Yes
7	Response	No	2/73.7	MRI	Yes	Yes	No	mMR	Yes
8	Response	No	1.75/65	MRI	Yes	Yes	No	mIR	Yes
9	Response	Yes	2.65/98	MRI	Yes	No	No	mCR	Yes
10	Response	Yes	1.3/47	MRI	Yes	No	No	mIR	Yes
11	Staging	No	2.75/102	Radiography, ultrasound, MRI	Yes	Yes	Yes	Metastatic disease	Yes
12	Response	Yes	1.48/55	MRI	Yes	No	No	mIR	Yes
13	Restaging	Yes	1/37	MRI	No	Yes	No	Lesion on MRI not ⁶⁸Ga-DOTATATE– avid	More accurate response on PET
14	Staging	Yes	2/74	CT, MRI	Yes	Yes	No	Numerous soft-tissue and bony lesions	PET identified additional lesions
15	Response	No	1.4/51.6	MRI	No	No	No	mCR	Yes

GA = general anesthesia; RT = radiopharmaceutical dose; mIR = metabolic incomplete response; PD = progressive disease; mMR = mixed metabolic response; mCR = complete metabolic response.